Related Experiment Video

Updated: Jul 6, 2026

An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses
10:35

An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses

Published on: November 28, 2010

Antigen-specific immunotherapy of cervical and ovarian cancer

Chien-Fu Hung1, T C Wu, Archana Monie

  • 1Department of Pathology, The Johns Hopkins School of Medicine, Baltimore, MD 21231, USA.

Immunological Reviews
|March 28, 2008
PubMed

Insights

Therapeutic cancer vaccines face challenges due to differing tumor biology. Cervical cancer vaccines target human papillomavirus (HPV) oncoproteins, while ovarian cancer vaccines focus on promising tumor-associated antigens like mesothelin.

Area of Science:

  • Oncology
  • Immunology
  • Vaccinology

Background:

  • Therapeutic cancer vaccines often target tumor-associated antigens (TAAs).
  • Cervical cancer is linked to human papillomavirus (HPV) oncoproteins (E6/E7), which are targets for vaccines.
  • Epithelial ovarian cancer etiology is less understood, complicating TAA selection and vaccine design.

Purpose of the Study:

  • To contrast vaccination strategies for ovarian and cervical cancers based on their distinct pathobiology.
  • To highlight mesothelin as a promising TAA for ovarian cancer therapeutic vaccines.

Main Methods:

  • Comparative analysis of vaccination approaches for cervical and ovarian cancers.
  • Focus on HPV oncoproteins as TAAs for cervical cancer.
  • Evaluation of mesothelin as a TAA for ovarian cancer.

Main Results:

  • Cervical cancer vaccination strategies leverage well-defined viral TAAs (HPV E6/E7).
  • Ovarian cancer TAA identification is challenging due to unknown etiology and precursor lesions.
  • Mesothelin is identified as a promising TAA for ovarian cancer due to overexpression, immunogenicity, and cell surface display.

Conclusions:

  • Different pathobiology necessitates distinct therapeutic vaccination strategies for ovarian and cervical cancers.
  • Targeting HPV oncoproteins is a viable strategy for cervical cancer vaccines.
  • Mesothelin holds promise as a target for ovarian cancer vaccines, warranting further investigation.

More Related Videos

In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model07:05

In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination Model

Published on: November 28, 2017

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...